China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024
Nucleic acid drugs have emerged as a rapidly growing sector in recent years. However, following the Covid-19 pandemic, the messenger ribonucleic acid (mRNA) drug market, initially buoyed by mRNA vaccines, has quickly shrunk. Companies like Stemirna …